Health and Fitness Health and Fitness
Tue, May 15, 2012
[ Tue, May 15th 2012 ] - Market Wire
CryoLife to Acquire Hemosphere
Mon, May 14, 2012
Sun, May 13, 2012
Sat, May 12, 2012
Fri, May 11, 2012
Thu, May 10, 2012
Wed, May 9, 2012
Tue, May 8, 2012
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
Tue, May 1, 2012

Hospira Convenes Its 2012 Annual Meeting of Shareholders


//health-fitness.news-articles.net/content/2012/ .. nes-its-2012-annual-meeting-of-shareholders.html
Published in Health and Fitness on Wednesday, May 9th 2012 at 10:35 GMT by Market Wire   Print publication without navigation


Hospira Convenes Its 2012 Annual Meeting of Shareholders -- LAKE FOREST, Ill., May 9, 2012 /PRNewswire/ --

Hospira Convenes Its 2012 Annual Meeting of Shareholders

[ ]

LAKE FOREST, Ill., May 9, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: [ HSP ]), the world's leading provider of injectable drugs and infusion technologies, today held its 2012 Annual Meeting of Shareholders in Arlington, Va. 

The agenda included votes on five items. During the annual meeting, shareholders:

  • elected the following directors: Barbara L. Bowles, Roger W. Hale and John C. Staley, all Class II directors whose terms expire in 2015; and William G. Dempsey, a Class III director whose term expires in 2013;
  • approved two amendments to Hospira's restated certificate of incorporation to permit shareholders to call special meetings in accordance with the company's bylaws and to phase out the classification of the board over a three-year period;
  • approved, by means of a shareholder advisory vote, the compensation of Hospira's named executive officers ("say on pay") as disclosed in the company's 2012 proxy statement; and
  • ratified the appointment of Deloitte & Touche LLP as Hospira's auditors for 2012.

A full description of the above matters is included in Hospira's proxy statement related to the meeting. The [ proxy statement ] and [ annual report ] is available on Hospira's website at [ www.hospirainvestor.com ].

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at [ www.hospira.com ].

SOURCE Hospira, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.hospira.com ]
[ http://www.hospirainvestor.com ]


Publication Contributing Sources